Comment on ′′gastrointestinal bleeding under dabigatran′′
Main Authors: | P Gélisse, A Crespel |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2014-01-01
|
Series: | Journal of Postgraduate Medicine |
Online Access: | http://www.jpgmonline.com/article.asp?issn=0022-3859;year=2014;volume=60;issue=4;spage=413;epage=414;aulast=Gélisse |
Similar Items
-
Gastrointestinal bleeding under dabigatran
by: C Stöllberger, et al.
Published: (2014-01-01) -
Safety and timing of resuming dabigatran after major gastrointestinal bleeding reversed by idarucizumab
by: Gian Galeazzo Riario Sforza, et al.
Published: (2018-01-01) -
Dabigatran etexilate - A novel oral anticoagulant for bleeding complications
by: Himabindu Reddy, et al.
Published: (2015-09-01) -
Failure to recognize muscular artifacts on the EEG may cause a wrong diagnosis of myoclonic status epilepticus
by: Philippe Gelisse, et al.
Published: (2020-01-01) -
Length of hospitalization and mortality for bleeding during treatment with warfarin, dabigatran, or rivaroxaban.
by: Blake Charlton, et al.
Published: (2018-01-01)